Lead Product(s) : Golvatinib
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 26, 2015
Lead Product(s) : Golvatinib
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 14, 2011
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Phase I Study of E7050 in Subjects With Solid Tumors
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 02, 2011
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Quintiles Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 18, 2011
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Quintiles Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : PharmaBio Development
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 11, 2011
Lead Product(s) : Golvatinib
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : PharmaBio Development
Deal Size : Inapplicable
Deal Type : Inapplicable